The UT Medical Center Cancer Institute Quality Measure Performance Rates
CANCER STATISTICS 2022
2022 Transplants 21 Autologous Transplants 4 Allogenic Transplants
2022 Cancer Institute Conference Presentations
American College of Surgeons Commission on Cancer (CoC) Quality of Care Measures The CoC develops quality measures and requires all CoC-accredited programs to treat cancer patients according to these nationally accepted standards. The University of Tennessee Medical Center has been CoC accredited since 1980. The performance of an individual program can be measured against the data from all other CoC-accredited programs (1500 cancer centers in the US) through the National Cancer Database. MadjRX Melanoma adjuvant systemic therapy was administered within 6 months of surgery or recommended for eligible patients with Stage IIIB-D resected melanoma BCSdx First therapeutic breast surgery in a non-neoadjuvant setting is performed within 60 days of diagnosis for patients with AJCC clinical stage I-III breast cancer GCTRT Neoadjuvant chemotherapy and/or chemo-radiation is administered within 120 days preoperatively for patients with AJCC cT2+ or cN1+, cM0 for gastric carcinoma; or (cT2 and poor differentiation) or cT3+ or cN1+, cM0 for esophageal or gastroesophageal junction carcinoma; age 18-79 GLN15 At least 15 regional lymph nodes are removed and pathologically examined for resected gastric cancer LCT Systemic chemotherapy is administered within 4 months to day preoperatively or day of surgery to 6 months postoperatively, or it is Fall 2014 recommended for surgically resected cases with pathologic, lymph node-positive (pN1) and (pN2) NSCLC BCSRT Radiation therapy is administered within 1 year (365 days) of diagnosis for women under age 70 receiving breast-conserving surgery for breast cancer Breast MAC Combination chemotherapy or chemo-immunotherapy (if HER2 positive), is recommended or administered within 4 months (120 days) of diagnosis for women under 70 with AJCC T1cN0M0, or stage IB-III hormone receptor negative breast cancer Colon ACT Adjuvant chemotherapy is recommended or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC Stage III (lymph node positive) colon cancer Colon 12 RLN At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer RCRM Circumferential margin is greater than 1 mm from the tumor to the inked, non-serosalized resection margin for rectal resections RECRTCT Preoperative chemo and radiation are administered for clinical AJCC T3N0, T4N0, or Stage III; or postoperative chemo and radiation are administered within 180 days of diagnosis for clinical AJCC T1-2N0 with pathologic AJCC T3N0, T4N0, or Stage III; or treatment is recommended; for patients under the age of 80 receiving resection for rectal cancer
ADDITIONAL CHART TBD
18 - Cancer Institute Annual Report 2022
19
Made with FlippingBook - professional solution for displaying marketing and sales documents online